Journal article
Ginkgo biloba extract: review of CNS effects
Annals of clinical psychiatry, Vol.15(2), pp.109-119
06/2003
DOI: 10.1023/A:1024688326023
PMID: 12938868
Abstract
The marketing of Ginkgo biloba extract (GBE) products is directed to the healthy, not diseased, population primarily for the promotion and maintenance of optimal brain function, not the treatment or prevention of any specific pathological state. However, recommendations are available for the use of GBE for a myriad of diseases that generally fall into one of three categories--cerebrovascular, peripheral vascular, or mitigation of tissue damage. The evidence for the pharmacological actions of GBE stem from one of three types of investigations--clinical studies in humans, pharmacological trials in animals, and in vitro studies. The purpose of this paper is to review the scientific literature on the central nervous system effects of GBE, with emphasis on the potential mechanisms of action. Limitations of the current scientific literature are highlighted and suggestions for future human and animal research directions are proposed.
Details
- Title: Subtitle
- Ginkgo biloba extract: review of CNS effects
- Creators
- Laura L Boles Ponto - Department of Radiology, Positron Emission Tomography Imaging Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. laura-ponto@uiowa.eduSusan K Schultz
- Resource Type
- Journal article
- Publication Details
- Annals of clinical psychiatry, Vol.15(2), pp.109-119
- Publisher
- United States
- DOI
- 10.1023/A:1024688326023
- PMID
- 12938868
- ISSN
- 1040-1237
- eISSN
- 1547-3325
- Language
- English
- Date published
- 06/2003
- Academic Unit
- Radiology; Psychiatry; Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984051885602771
Metrics
33 Record Views